Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|February 23, 2007
Mast cell tryptase beta as a target in allergic inflammation: an evolving storyC P Sommerhoff, N SchaschkeFEBS Letters|February 14, 1998
Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitorsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.Bioorganic & Medicinal Chemistry|November 14, 1997
E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl groupN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.FEBS Letters|October 6, 2000
Epoxysuccinyl peptide-derived affinity labels for cathepsin BN Schaschke, I Assfalg-Machleidt, T Lassleben, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2000
Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cellsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.FEBS Letters|August 12, 1996
Cyclodextrins as templates for the presentation of protease inhibitorsN Schaschke, H J Musiol, I Assfalg-Machleidt, et al.Chemistry & Biology|April 28, 2001
Bivalent inhibition of human beta-tryptaseN Schaschke, G Matschiner, F Zettl, et al.Angewandte Chemie (International Ed. in English)|July 1, 2014
Selective targeting of tumor and stromal cells by a nanocarrier system displaying lipidated cathepsin B inhibitorG Mikhaylov, D Klimpel, N Schaschke, et al.Pageof 1